The Role of the Polyol Pathway in Diabetic Retinopathy
Author Information
Author(s): Mara Lorenzi
Primary Institution: Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School
Hypothesis
Is the polyol pathway an important mechanism in diabetic retinopathy?
Conclusion
The polyol pathway is active in the human retina and contributes to diabetic retinopathy through oxidative stress and other mechanisms.
Supporting Evidence
- The polyol pathway becomes active when glucose levels are high, leading to cellular damage.
- Inhibition of aldose reductase can prevent diabetic retinopathy in animal models.
- Human retinas show increased aldose reductase activity in diabetes, indicating the pathway's relevance.
Takeaway
The polyol pathway is a process in the body that can cause damage in the eyes of people with diabetes, leading to vision problems. Researchers are looking for better ways to treat this issue.
Methodology
The review discusses various studies on the polyol pathway's role in diabetic retinopathy, including animal models and clinical trials.
Limitations
The review highlights the lack of effective drugs that can reliably inhibit the polyol pathway in humans.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website